These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23772771)

  • 41. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
    Peacock HM; Caolo V; Jones EA
    Cardiovasc Res; 2016 Feb; 109(2):196-203. PubMed ID: 26645978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary Hypertension in a Large Cohort with Hereditary Hemorrhagic Telangiectasia.
    Vorselaars V; Velthuis S; van Gent M; Westermann C; Snijder R; Mager J; Post M
    Respiration; 2017; 94(3):242-250. PubMed ID: 28743113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
    Fleagle JM; Bobba RK; Kardinal CG; Freter CE
    Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
    Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia.
    Jirillo E; Amati L; Suppressa P; Cirimele D; Guastamacchia E; Covelli V; Tafaro E; Sabbà C
    Curr Pharm Des; 2006; 12(10):1195-200. PubMed ID: 16611100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with
    Guilhem A; Dupuis-Girod S; Espitia O; Rivière S; Seguier J; Kerjouan M; Lavigne C; Maillard H; Magro P; Alric L; Lipsker D; Parrot A; Leguy V; Vanlemmens C; Guibaud L; Vikkula M; Eyries M; Valette PJ; Giraud S
    J Med Genet; 2023 Sep; 60(9):905-909. PubMed ID: 36813543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia.
    Azzopardi N; Dupuis-Girod S; Ternant D; Fargeton AE; Ginon I; Faure F; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Leguy-Seguin V; Rivière S; Corre R; Bailly S; Paintaud G
    MAbs; 2015; 7(3):630-7. PubMed ID: 25751241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immune profile of elderly patients admitted in a geriatric short care unit].
    Crétel E; Veen I; Pierres A; Binan Y; Robert P; Loundou AD; Baumstarck-Barrau K; Hubert AM; Bongrand P; Heim M
    Rev Med Interne; 2011 May; 32(5):275-82. PubMed ID: 21112131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia.
    Elphick A; Shovlin CL
    Laryngoscope; 2014 Jul; 124(7):1521-8. PubMed ID: 24458873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome: a cohort study in China.
    Lu QB; Cui N; Hu JG; Chen WW; Xu W; Li H; Zhang XA; Ly H; Liu W; Cao WC
    Vaccine; 2015 Mar; 33(10):1250-5. PubMed ID: 25645176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasia.
    Vorselaars VMM; Diederik A; Prabhudesai V; Velthuis S; Vos JA; Snijder RJ; Westermann CJJ; Mulder BJ; Ploos van Amstel JK; Mager JJ; Faughnan ME; Post MC
    Int J Cardiol; 2017 Oct; 245():114-118. PubMed ID: 28874282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial quality of life in hereditary haemorrhagic telangiectasia patients.
    Loaëc M; Morinière S; Hitier M; Ferrant O; Plauchu H; Babin E
    Rhinology; 2011 Jun; 49(2):164-7. PubMed ID: 21743870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark.
    Hvelplund T; Lange B; Bird SD; Korsholm M; Kjeldsen AD
    Orphanet J Rare Dis; 2022 Jan; 17(1):8. PubMed ID: 34991676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study.
    Pierucci P; Lenato GM; Suppressa P; Lastella P; Triggiani V; Valerio R; Comelli M; Salvante D; Stella A; Resta N; Logroscino G; Resta F; Sabbà C
    Orphanet J Rare Dis; 2012 Jun; 7():33. PubMed ID: 22676497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life.
    Easey AJ; Wallace GM; Hughes JM; Jackson JE; Taylor WJ; Shovlin CL
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):743-8. PubMed ID: 12754343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Living with Hereditary Haemorrhagic Telangiectasia: stigma, coping with unpredictable symptoms, and self-advocacy.
    Sexton A; Gargan B; Taylor J; Bogwitz M; Winship I
    Psychol Health; 2019 Oct; 34(10):1141-1160. PubMed ID: 30931645
    [No Abstract]   [Full Text] [Related]  

  • 58. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia.
    Al-Aska A; Al-Anazi AR; Al-Subaei SS; Al-Hedaithy MA; Barry MA; Somily AM; Buba F; Yusuf U; Al Anazi NA
    Eur J Med Res; 2011 Jun; 16(6):285-8. PubMed ID: 21810564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study.
    Donaldson JW; McKeever TM; Hall IP; Hubbard RB; Fogarty AW
    Thorax; 2014 Feb; 69(2):161-7. PubMed ID: 24188926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia.
    Droege F; Pylaeva E; Siakaeva E; Bordbari S; Spyra I; Thangavelu K; Lueb C; Domnich M; Lang S; Geisthoff U; Jablonska J
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32178330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.